A single‐center, open‐label, randomized cross‐over study to evaluate the pharmacokinetics and bioavailability of once‐daily prolonged‐release formulations of tacrolimus in de novo liver transplant recipients-Reference-Cited by-同舟云学术

A single‐center, open‐label, randomized cross‐over study to evaluate the pharmacokinetics and bioavailability of once‐daily prolonged‐release formulations of tacrolimus in de novo liver transplant recipients

Published:2021-09-24 Issue:4 Volume:9 Page:1771-1780
ISSN:2050-4527
Container-title:Immunity, Inflammation and Disease
language:en
Short-container-title:Immun Inflamm Dis

Author:

Herden Uta¹^ORCID,Sterneck Martina²,Buchholz Bettina M.¹,Achilles Eike G.¹,Ott Armin³,Fischer Lutz¹

Affiliation:

1. Department of Visceral Transplantation University Medical Center Hamburg‐Eppendorf Hamburg Germany

2. Department of Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany

3. Institute of Medical Informatics, Statistics and Epidemiology Technische Universität München Munich Germany

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.537

Reference20 articles.

1. Organ US Procurement and Transplantation Network. Scientific registry of transplant recipients.2012.

2. Present state of immunosuppressive therapy in liver transplant recipients

3. Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management

4. Pharmacokinetics of FK 506 in transplant patients;Venkataramanan R;Transplant Proc,1991

5. Early tacrolimus exposure after liver transplantation: Relationship with moderate/severe acute rejection and long-term outcome

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of once‐daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study;Clinical Transplantation;2023-08-24

2. The efficacy and tolerability of inhaled nitrous oxide in major depressive disorder: a systematic review and meta-analysis;Psychopharmacology;2023-08-23